Trial intelligence / Profile preview

Phase II TRUST study of AB-106 in ROS1-positive advanced non-small cell lung cancer

CTR20200869Phase 2Active

Sponsor

AnHeart Therapeutics

Start

Jul 2020

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1